Published in Medical Letter on the CDC and FDA, May 19th, 1997
Co-sponsors included the National Institute of Diabetes and Digestive and Kidney Diseases; the Office of Medical Applications of Research of the National Institutes of Health; the National Institute of Allergy and Infectious Diseases; the National Heart, Lung and Blood Institute; the National Institute on Drug Abuse; and the Centers for Disease Control and Prevention.
Following a day and a half of expert testimony and discussion from the audience, a draft of the Consensus Development Conference Statement was released; the final version is due...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.